Literature DB >> 22782295

Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Paul K Crane1, Adam Carle, Laura E Gibbons, Philip Insel, R Scott Mackin, Alden Gross, Richard N Jones, Shubhabrata Mukherjee, S McKay Curtis, Danielle Harvey, Michael Weiner, Dan Mungas.   

Abstract

We sought to develop and evaluate a composite memory score from the neuropsychological battery used in the Alzheimer's Disease (AD) Neuroimaging Initiative (ADNI). We used modern psychometric approaches to analyze longitudinal Rey Auditory Verbal Learning Test (RAVLT, 2 versions), AD Assessment Schedule - Cognition (ADAS-Cog, 3 versions), Mini-Mental State Examination (MMSE), and Logical Memory data to develop ADNI-Mem, a composite memory score. We compared RAVLT and ADAS-Cog versions, and compared ADNI-Mem to RAVLT recall sum scores, four ADAS-Cog-derived scores, the MMSE, and the Clinical Dementia Rating Sum of Boxes. We evaluated rates of decline in normal cognition, mild cognitive impairment (MCI), and AD, ability to predict conversion from MCI to AD, strength of association with selected imaging parameters, and ability to differentiate rates of decline between participants with and without AD cerebrospinal fluid (CSF) signatures. The second version of the RAVLT was harder than the first. The ADAS-Cog versions were of similar difficulty. ADNI-Mem was slightly better at detecting change than total RAVLT recall scores. It was as good as or better than all of the other scores at predicting conversion from MCI to AD. It was associated with all our selected imaging parameters for people with MCI and AD. Participants with MCI with an AD CSF signature had somewhat more rapid decline than did those without. This paper illustrates appropriate methods for addressing the different versions of word lists, and demonstrates the additional power to be gleaned with a psychometrically sound composite memory score.

Entities:  

Mesh:

Year:  2012        PMID: 22782295      PMCID: PMC3806057          DOI: 10.1007/s11682-012-9186-z

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  20 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Memory and executive function in older adults: relationships with temporal and prefrontal gray matter volumes and white matter hyperintensities.

Authors:  Cyma Van Petten; Elena Plante; Patrick S R Davidson; Trudy Y Kuo; Leslie Bajuscak; Elizabeth L Glisky
Journal:  Neuropsychologia       Date:  2004       Impact factor: 3.139

3.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

4.  Memory in the aging brain: doubly dissociating the contribution of the hippocampus and entorhinal cortex.

Authors:  Andrew P Yonelinas; Keith Widaman; Dan Mungas; Bruce Reed; Michael W Weiner; Helena C Chui
Journal:  Hippocampus       Date:  2007       Impact factor: 3.899

5.  The role of the bifactor model in resolving dimensionality issues in health outcomes measures.

Authors:  Steven P Reise; Julien Morizot; Ron D Hays
Journal:  Qual Life Res       Date:  2007-05-04       Impact factor: 4.147

6.  Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Authors:  R C Mohs; D Knopman; R C Petersen; S H Ferris; C Ernesto; M Grundman; M Sano; L Bieliauskas; D Geldmacher; C Clark; L J Thal
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

7.  Confirmatory factor analysis and item response theory: two approaches for exploring measurement invariance.

Authors:  Steven P Reise; Keith F Widaman; Robin H Pugh
Journal:  Psychol Bull       Date:  1993-11       Impact factor: 17.737

8.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Application of item response theory for development of a global functioning measure of dementia with linear measurement properties.

Authors:  D Mungas; B R Reed
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

10.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

View more
  218 in total

1.  Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Authors:  Daniela Bertens; Dirk L Knol; Philip Scheltens; Pieter Jelle Visser
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

2.  Genetic modification of the relationship between phosphorylated tau and neurodegeneration.

Authors:  Timothy J Hohman; Mary Ellen I Koran; Tricia A Thornton-Wells
Journal:  Alzheimers Dement       Date:  2014-03-20       Impact factor: 21.566

3.  Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.

Authors:  Adam P Mecca; Hannah R Michalak; Julia W McDonald; Emily C Kemp; Erika A Pugh; Melinda L Becker; Marcia C Mecca; Christopher H van Dyck
Journal:  Dement Geriatr Cogn Disord       Date:  2018-06-08       Impact factor: 2.959

4.  Detecting biological heterogeneity patterns in ADNI amnestic mild cognitive impairment based on volumetric MRI.

Authors:  Ali Ezzati; Andrea R Zammit; Christian Habeck; Charles B Hall; Richard B Lipton
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

5.  Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance.

Authors:  Alexandra Plagman; Siobhan Hoscheidt; Kelsey E McLimans; Brandon Klinedinst; Colleen Pappas; Vellareddy Anantharam; Anumantha Kanthasamy; Auriel A Willette
Journal:  Neurobiol Aging       Date:  2019-01-09       Impact factor: 4.673

6.  Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.

Authors:  Jeremy A Elman; Matthew S Panizzon; Daniel E Gustavson; Carol E Franz; Mark E Sanderson-Cimino; Michael J Lyons; William S Kremen
Journal:  Biol Psychiatry       Date:  2020-01-07       Impact factor: 13.382

Review 7.  The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Authors:  Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2014-06       Impact factor: 4.384

8.  CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.

Authors:  Boris-Stephan Rauchmann; Thomas Schneider-Axmann; Panagiotis Alexopoulos; Robert Perneczky
Journal:  Neurobiol Aging       Date:  2018-10-25       Impact factor: 4.673

9.  Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer's Disease.

Authors:  Ling-Zhi Ma; Zi-Xuan Wang; Zuo-Teng Wang; Xiao-He Hou; Xue-Ning Shen; Ya-Nan Ou; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Neurotox Res       Date:  2020-11-20       Impact factor: 3.911

10.  Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.

Authors:  Eun Hyun Seo; I L Han Choo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-28       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.